Luo et al. reported significantly elevated IL-6 activity in patients with ALL compared with that in healthy controls, and in vitro studies demonstrated that IL-6 promotes leukaemic cell proliferation (49). This evidence concerns the gene IL6 and acute lymphoblastic leukemia.